Austrian enforcer settles predatory pricing probe into Merck
Credit: Shutterstock/Tada Images
Austria's Federal Competition Authority has accepted commitments from pharmaceutical company Merck Sharp & Dohme's local subsidiary to stop charging predatory prices for a brain tumour drug.
To read more
Subscribe to Global Competition Review
Subscribe and start reading now
Global Competition Review (GCR) is the complete source of news and analysis for competition practitioners. It keeps you up to speed with the issues and trends that matter, giving you the detail, and depth, you need to operate successfully.
Subscribe now
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10